Google announced the formation of a new parent company, called Alphabet, as well as plans to increase its focus on healthcare-related initiatives starting with a partnership that will develop low-cost sensors to improve diabetes management.
The company's life sciences team, part of the Alphabet unit run by CEO Larry Page and President Sergey Brin, and DexCom will work together to build continuous glucose monitoring (CGM) devices, incorporating Google's miniaturized electronics platform with the San Diego-based company's sensor technology.
Alphabet and Dexcom will focus on creating miniaturized, low-cost and disposable CGM body-worn components that can replace finger sticks and allow patients to use the tools to better control their diabetes with actionable information.
"We're committed to developing new technologies that will help move healthcare from reactive to proactive," Andrew Conrad, head of the life sciences team at Alphabet, said in a release.
Editor
Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.